ArticleCurrent neuropharmacology2026
Association between Suicidal Ideation and Immune Parameters in First-episode Patients with Schizophrenia.
Article in Current neuropharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDisturbed immunity and inflammation have been associated with the pathogenesis of schizophrenia (SZ) and suicidal behaviors. We hypothesized that the neutrophil-tolymphocyte ratio (NLR) was associated with the increased risk of suicide ideation (SI) in patients with SZ.
methodsA total of 97 drug-naïve first-episode patients with SZ (15 with SI and 82 without SI) were recruited in the present study. The symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS), and differential white cell counts and SI were assessed for all patients.
resultsPatients in the SI group had higher NLR values and more severe clinical symptoms than the non-SI group (all p<0.05). Differences remained significant when controlling for smoking, sex, BMI, and age. Logistic regression analysis showed that NLR was an independent predictor of SI in firstepisode patients with SZ after controlling for clinical symptoms, smoking status, marital status, education, sex, body mass index (BMI), and age. DISCUSSION: This study indicates a predictive role of NLR in SI at the first onset of SZ. It also suggests that monitoring NLR could be a useful clinical tool for identifying patients who may be at higher risk for SI, particularly at the onset of the disorder.
conclusionOur findings add to the understanding of the biological factors that may contribute to SI in SZ.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.